Parametric Portfolio Associates’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$119K Buy
17,270
+4,237
+33% +$30K ﹤0.01% 3537
2021
Q4
$91K Sell
13,033
-1,736
-12% -$13.9K ﹤0.01% 3563
2021
Q3
$124K Buy
14,769
+883
+6% +$6.47K ﹤0.01% 3508
2021
Q2
$97K Sell
13,886
-859
-6% -$6.02K ﹤0.01% 3487
2021
Q1
$91K Buy
+14,745
New +$97.7K ﹤0.01% 3977
2020
Q4
Sell
-12,581
Closed -$55K 4039
2020
Q3
$55K Buy
+12,581
New +$61.3K ﹤0.01% 3857
2020
Q2
Sell
-10,072
Closed -$61K 4020
2020
Q1
$61K Hold
10,072
﹤0.01% 3811
2019
Q4
$92K Buy
+10,072
New +$93K ﹤0.01% 3870

Other funds holding PMD

Parametric Portfolio Associates's PMD Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Psychemedics Corporation (PMD) stake by 33% in Q1 2022, buying an estimated $30K and bringing the position to 17,270 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3537.

Parametric Portfolio Associates first reported a position in PMD in Q4 2019 and has held it in 8 quarters since. The position peaked at $124K in Q3 2021. 25 funds tracked by Wall St. Rank hold PMD as of Q1 2022.

  • Parametric Portfolio Associates held 17,270 shares of Psychemedics Corporation worth $119K as of Q1 2022.
  • Parametric Portfolio Associates bought 4,237 Psychemedics Corporation shares in Q1 2022, an estimated $30K.
  • Psychemedics Corporation made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3537 holding.
  • Parametric Portfolio Associates first reported a position in Psychemedics Corporation in Q4 2019 and has held it in 8 quarters since.
  • Parametric Portfolio Associates's Psychemedics Corporation position peaked at $124K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.